flomoxef has been researched along with cefotaxime in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
| Heizmann, W; Luft, G; Werner, H | 1 |
| Hirano, Y; Maruyama, S; Sakata, H | 1 |
| Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
| Hamada, T; Kodama, H; Osaki, T; Ueta, E | 1 |
7 other study(ies) available for flomoxef and cefotaxime
| Article | Year |
|---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
[Clinical efficacy of flomoxef in neonatal bacterial infection].
Topics: Ampicillin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn | 1993 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities.
Topics: Adult; Animals; Area Under Curve; Cefotaxime; Cefozopran; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Diffusion; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Kinetics; Male; Perfusion; Protein Binding; Rats; Rats, Sprague-Dawley; Saliva; Statistics, Nonparametric | 2002 |